<DOC>
	<DOCNO>NCT00683800</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Desvenlafaxine Succinate ( DVS ) Sustained Release ( SR ) , comparison placebo treatment Vasomotor Symptoms ( VMS ) menopausal woman .</brief_summary>
	<brief_title>Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Generally healthy , postmenopausal woman seek treatment hot flush Body Mass Index ( BMI ) less equal 34 kg/m^2 Hypersensitivity Venlafaxine Myocardial infarction an/or unstable angina within 6 month screen History seizure disorder</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Hot Flush</keyword>
	<keyword>Hot Flash</keyword>
	<keyword>Desvenlafaxine succinate Sustained Release</keyword>
</DOC>